Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01232933 · ClinicalTrials.gov registry record · NA
Use of the VasoNova VPS System During PICC Placement in an Algorithm Confirmation Study Using Fluoroscopy
A NA study of Any Condition Requiring a PICC Placement, sponsored by VasoNova.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
- 1
- Study location
NCT01232933: Completed NA study of Any Condition Requiring a PICC Placement, sponsored by VasoNova.
NCT01232933 is a NA study of Any Condition Requiring a PICC Placement that has completed, run by VasoNova. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01232933, a NA study of Any Condition Requiring a PICC Placement, has completed, sponsored by VasoNova.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects meeting study requirements will be consented and have their PICC catheter placed using navigational technology and the tip placement confirmed with radiographic imaging.
Conditions Studied
Interventions
- DEVICE VPS System
Study Locations (1)
District of Columbia
- Georgetown University Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2010-06 |
| Est. Completion | 2010-10 |
| Phase | NA |
What the finished NCT01232933 record still lists
NCT01232933 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Any Condition Requiring a PICC Placement appearing as the primary indexed condition, and to 1 intervention - of which VPS System is the first listed.
NCT01232933 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT01232933 about?
NCT01232933 is a clinical study titled "Use of the VasoNova VPS System During PICC Placement in an Algorithm Confirmation Study Using Fluoroscopy". Subjects meeting study requirements will be consented and have their PICC catheter placed using navigational technology and the tip placement confirmed with radiographic imaging.
What is the current status of trial NCT01232933?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2010-06. Estimated completion is 2010-10.
What conditions does trial NCT01232933 study?
This clinical trial studies the following conditions: Any Condition Requiring a PICC Placement.
What interventions are being tested in trial NCT01232933?
The interventions under investigation include: VPS System (DEVICE).
Who is sponsoring clinical trial NCT01232933?
This trial is sponsored by VasoNova, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01232933 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01232933's enrollment target sits among peer trials
83 990th of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia